4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-012396
SVP, Chief Accounting Officer sold 1,430 shares at $9.53 ($13,632)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sabatini Brent SVP, Chief Accounting Officer | 2026-02-24 | Sale 10b5-1 | −1,430 | $9.53 | $13,632 | 69,613 | D |
| Open-market sales · 1,430 sh · avg $9.53 · $13,632 | |||||||
Loading xslF345X05/wk-form4_1772142963.xml…